期刊文献+

胃内滞留漂浮型给药系统的研究进展 被引量:6

下载PDF
导出
摘要 胃内滞留漂浮型给药系统(gastric retenting floating drug delivery system,GRFDDS)为一类重要的口服缓控释给药系统,该类制剂是一类能延长药物在胃内滞留时间,增加药物在胃或十二指肠的吸收程度,降低毒副作用,稳定血药浓度,减少服药次数,提高临床疗效的新型制剂。经过近几年的研究,胃内滞留漂浮型制剂获得了长足的进步,
出处 《河北医科大学学报》 CAS 2009年第3期320-324,共5页 Journal of Hebei Medical University
  • 相关文献

参考文献18

  • 1HOU SY, COWLES VE, BERNER B. Castric retentive dosage forms[J]. Crit Rev Ther Drug Carrier Syst,2003,20 (6) :459.
  • 2GOOLE J,VANDERBIST F, AMIGHI K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms[J]. Int J Pham,2007,334(1-2) :35-41.
  • 3SUNGTHONGJEEN S, PAERATAKUL O, LIMMATVAPIRAT S, et al. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique[J]. Int J Pham, 2006,324 (2) :136-143.
  • 4JAIN SK,AWASTHI AM,JAIN NK. Calcium silicate based mierospheres of repaglinide for gastrorelentive floating drug delivery preparation and in vitro characterization [J ]. J Cont roll Release, 2005,107 ( 2 ): 300-309.
  • 5SRIAMORNSAK P, THIRAWONG N, PUTTIPIPATKHACHORN S. Emulsion gel beads of calcium pectinate capable of floating on the gastric fluid: effect of some additives, hardening agent or coating on release behavior of metronidazole[J]. Eur J Pham Sci,2005,24(4):363-373.
  • 6赵新慧,刘陶世,段金廒.羟丙基甲基纤维素对左金胃漂浮缓释片的漂浮性能和药物释放特征的影响[J].中成药,2007,29(7):988-992. 被引量:10
  • 7朴洪泽,林文辉,李翠芳,方亮,崔福德.辅料因素对胃漂浮片的制备及漂浮能力的影响[J].沈阳药科大学学报,2008,25(2):89-95. 被引量:9
  • 8尹莉芳,程开生,王广基,张陆勇,臧洪梅,周建平.薄膜包衣对头孢氨苄胃内漂浮片的影响[J].中国药科大学学报,2008,39(1):37-41. 被引量:2
  • 9SATO Y,KAWASHIMA Y, TAKEUCHI H, et al. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans[J]. Int J Pharm,2004,275(1 2) :97-107.
  • 10孙维广,郝吉福,孔志峰,郭丰广,靳晓秋,程怡.小剂量阿司匹林胃漂浮胶囊的制备及其体外释药特征的研究[J].中国药房,2006,17(13):972-974. 被引量:2

二级参考文献70

共引文献71

同被引文献64

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部